Cell Signaling Technology

Phospho-HSP90 alpha (Thr5/7) Antibody

#3488 · $362

100
Citing papers
10.5k
Combined citations
Supplier page Find this product

Research areas

Cancer Cells and Metastasis12Cancer Genomics and Diagnostics6Genomics and Chromatin Dynamics6Wnt/β-catenin signaling in development and cancer5Adipokines, Inflammation, and Metabolic Diseases5Cancer Immunotherapy and Biomarkers5Immune Cell Function and Interaction5Cancer-related gene regulation4

Papers citing this product

1
Implications of the tumor immune microenvironment for staging and therapeutics
Modern Pathology·2017·364 cit.·DOI
2
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
Journal for ImmunoTherapy of Cancer·2020·284 cit.·DOI
3
Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer
Cell·2023·280 cit.·DOI
4
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Breast Cancer Research·2007·228 cit.·DOI
5
ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif
Nucleic Acids Research·2011·226 cit.·DOI
6
Elevated Levels of G-Quadruplex Formation in Human Stomach and Liver Cancer Tissues
PLoS ONE·2014·223 cit.·DOI
7
How Linear Tension Converts to Curvature: Geometric Control of Bone Tissue Growth
PLoS ONE·2012·221 cit.·DOI
8
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Clinical Cancer Research·2017·220 cit.·DOI
9
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axis
The Journal of Experimental Medicine·2011·203 cit.·DOI
10
Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells
Proceedings of the National Academy of Sciences·2016·192 cit.·DOI